MEI Pharma rebrands as Lite Strategy, Inc., adopts digital asset treasury with LTC

Lite Strategy, Inc.

Company changes name to Lite Strategy, Inc.; NASDAQ ticker changes from MEIP to LITS effective Sep 11, 2025.
Holds over $100M in Litecoin (LTC) as primary reserve asset; advised by GSR for liquidity and risk management.
LTC creator Charlie Lee joins board; continues preclinical evaluation of voruciclib and zandelisib.

item 5.03 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Lite Strategy, Inc.: Changed corporate name from MEI Pharma, Inc. to Lite Strategy, Inc (effective 2025-09-10).

Change: charter amendment
Effective: 2025-09-10

Exact text from the filing

Effective September 10, 2025, MEI Pharma, Inc. (the “Company”) changed its name to Lite Strategy, Inc. pursuant to an amendment to its amended and restated certificate of incorporation filed with the Secretary of State of the State of Delaware (the “Name Change”).

View on SEC.gov

244 governance changes filed in the last 30 days. Browse all governance changes →

Lite Strategy, Inc. filing history →

Source: SEC EDGAR

accession 0001262104-25-000009

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.